MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Iterum Therapeutics Shares 2011-2025 | ITRM
Annual Shares Iterum Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.7 M | 13 M | 12.2 M | 10.9 M | 1.6 M | 14.5 M | 14.4 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.7 M | 1.6 M | 12.3 M |
Quarterly Shares Iterum Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.8 M | 39.9 M | 34.1 M | 20 M | 16.6 M | 15.4 M | 13 M | 12.9 M | 12.7 M | - | 12.2 M | 12.2 M | 12.2 M | - | 12.2 M | 180 M | 122 M | 40.6 M | 20.4 M | 15.6 M | 14.9 M | 14.9 M | 14.6 M | 14.3 M | 14.3 M | 14.1 M | 14 M | 7.09 M | 198 K | - | 185 K | 159 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 180 M | 159 K | 25.7 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
77.3 M | $ 2.9 | -3.65 % | $ 224 M |  USA |
 |
Autolus Therapeutics plc
AUTL
|
255 M | $ 1.97 | 5.35 % | $ 503 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
2.41 B | $ 3.06 | -0.33 % | $ 7.36 B |  Australia |
 |
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | USA |
 |
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M |  France |
 |
Aptorum Group Limited
APM
|
5.45 M | $ 1.11 | 2.78 % | $ 6.05 M |  China |
 |
BioVie
BIVI
|
1.48 M | $ 1.13 | -8.13 % | $ 1.67 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
60.3 M | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | USA |
 |
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | USA |
 |
Ascendis Pharma A/S
ASND
|
54.8 M | $ 209.32 | -0.81 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | USA |
 |
Avenue Therapeutics
ATXI
|
1.3 M | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
44.3 M | - | 1083.1 % | $ 745 M | USA |
 |
BioDelivery Sciences International
BDSI
|
99.3 M | - | -4.8 % | $ 255 M | USA |
 |
Athersys
ATHX
|
224 M | - | 3.77 % | $ 22.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - |  Russia |
 |
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
30.8 M | - | -9.72 % | $ 5.89 M | USA |
 |
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M |  Canada |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.18 B | $ 0.18 | 7.52 % | $ 392 M |  Israel |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.21 B | - | -15.15 % | $ 60.3 M | Britain |
 |
Catalyst Biosciences
CBIO
|
65.8 M | $ 11.6 | -3.97 % | $ 764 M | USA |
 |
Berkeley Lights
BLI
|
68.9 M | - | -7.31 % | $ 87 M | USA |
 |
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | USA |
 |
BioNTech SE
BNTX
|
244 M | $ 95.28 | 0.08 % | $ 27.2 B | Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
48.4 M | $ 27.0 | 0.78 % | $ 1.31 B | USA |
 |
BeiGene, Ltd.
BGNE
|
1.37 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Calithera Biosciences
CALA
|
73.9 M | - | -10.95 % | $ 876 K | USA |
 |
Certara
CERT
|
160 M | $ 8.86 | 0.11 % | $ 1.42 B | USA |
 |
Anika Therapeutics
ANIK
|
14.7 M | $ 9.55 | 0.21 % | $ 140 M | USA |
 |
bluebird bio
BLUE
|
110 M | - | - | $ 546 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
60.8 M | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | USA |
 |
Cellectis S.A.
CLLS
|
44.8 M | $ 4.78 | -3.63 % | $ 116 M | France |
 |
Axon Enterprise
AXON
|
75.7 M | $ 572.11 | -1.45 % | $ 43.3 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
6.28 M | $ 2.55 | 0.39 % | $ 16 M | USA |
 |
ChromaDex Corporation
CDXC
|
75.9 M | - | -0.88 % | $ 598 M | USA |
 |
AstraZeneca PLC
AZN
|
1.42 B | $ 92.51 | -0.01 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
5.39 M | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
219 M | $ 9.01 | -2.59 % | $ 1.46 B | Britain |
 |
Celldex Therapeutics
CLDX
|
64.4 K | $ 26.43 | 1.54 % | $ 1.7 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
64.7 M | $ 11.64 | 0.87 % | $ 753 M | USA |